Valencia Quintero, J.S. and Castillo, D. (2023) “Venglustat, Lanreotide Acetate, and Tolvaptan as therapeutic options for the treatment of autosomic dominant polychistic kidney disease: a narrative review”, Interdisciplinary Journal of Epidemiology and Public Health, 3(2), p. e-7246. doi:10.18041/2665-427X/ijeph.2.7246.